Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats. (Q50615721)
Jump to navigation
Jump to search
scientific article published on 5 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats. |
scientific article published on 5 August 2011 |
Statements
1 reference
Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats. (English)
1 reference
María Laura Sbaraglini
1 reference
Antonio Desmond McCarthy
1 reference
María Silvina Molinuevo
1 reference
Juan Ignacio Felice
1 reference
Claudia Sedlinsky
1 reference
Ana María Cortizo
1 reference
María José Tolosa
1 reference
Leon Schurman
1 reference
5 August 2011
1 reference
668
1 reference
3
1 reference
477-485
1 reference
Identifiers
1 reference